Drugs that contain Abemaciclib
1. List of Verzenio drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7855211 | ELI LILLY AND CO | Protein kinase inhibitors |
Dec, 2029
(6 years from now) | |
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Patient Population (NPP) | Oct 12, 2024 |
| New Indication (I) | Oct 12, 2024 |
Market Authorisation Date: 28 September, 2017
Treatment: In combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (h...
Dosage: TABLET;ORAL
VERZENIO family patents
4
United States
2
European Union
1
Colombia
1
Ecuador
1
Panama
1
Luxembourg
1
Australia
1
EA
1
Israel
1
Croatia
1
Dominican Republic
1
Korea, Republic of
1
Canada
1
Netherlands
1
New Zealand
1
Denmark
1
Honduras
1
Spain
1
Tunisia
1
Peru
1
Malaysia
1
Costa Rica
1
Chile
1
Cyprus
1
Singapore
1
Jordan
1
Portugal
1
Ukraine
1
Poland
1
Japan
1
Morocco
1
Norway
1
Hong Kong
1
Slovenia
1
Mexico
1
Guatemala
1
Argentina
1
RS
1
China
1
South Africa
1
Brazil
1
Hungary
1
Taiwan
1
Lithuania
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic